|
COPYRIGHT 2005 International Medical News Group
Infliximab significantly reduced the rate of colectomy in patients who had severe or moderately severe ulcerative colitis that was refractory to conventional treatment, reported Gunnar Jarnerot, M.D., of Orebro (Sweden) University Hospital, and associates.
In an interim analysis of a randomized, double-blind trial that was ended early because of...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
